Navigation Links
Muscle-invasive and non-muscle invasive bladder cancers arise from different stem cells
Date:12/17/2013

Bladder cancer will kill upward of 170,000 people worldwide this year, but bladder cancer isn't fatal in the bladder. Instead, in order to be fatal the disease must metastasize to faraway sites. The question has been this: does localized, non-muscle invasive (NMI) bladder cancer eventually become the more dangerous, muscle-invasive (MI) form of the disease, or are NMI and MI bladder cancers genetically distinct from the start?

A University of Colorado Cancer Center study published today in the journal Stem Cells shows it's the latter: the progenitor cells that create MI bladder cancer are different than the progenitor cells that create NMI bladder cancer. Though these two cancers grow at the same site, they are different diseases.

"This work provides an important new perspective on how we look at bladder cancer biology," says Dan Theodorescu, MD, PhD, director of the University of Colorado Cancer Center and the study's senior author.

The group including first author Garrett Dancik, PhD, genetically profiled two cell types that could give rise to bladder cancer the basal and umbrella layers of the normal bladder lining (urothelium) to discover the gene signatures specific to each of these cell populations.

Then the group compared these gene signatures to human bladder cancer samples. The tumor samples were distinct: those with the signature of umbrella cells were likely to be lower stage and patients eventually had favorable outcomes; tumors with the signatures of basal layer cells were likely to be higher stage and patients eventually had worse outcomes.

"We saw a fairly stark difference between these tumor types: those with basal signatures were distinctly more aggressive than those with umbrella signatures," Theodorescu says. In fact, these signatures predicted tumor stage and patient survival better than many existing prognostic markers.

"Our results suggests that NMI cells arise from non-basal cells, whereas MI tumors arise from basal cells," Theodorescu says.

"This may be an important biomarker for prognosis," Theodorescu says. "With additional testing, we could use the signature to predict how aggressive a bladder cancer is likely to be. Knowing the risk can help doctors and patients make informed treatment decisions."


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert  

Related biology news :

1. Peaceful bumblebee becomes invasive
2. USF researchers show invasive sparrows immune cells sharpen as they spread
3. Edited RNA + invasive DNA add individuality
4. Angel or demon: Can a potentially invasive plant bring a positive influence to a region?
5. Adaptability to local climate helps invasive species thrive
6. Texas Invasive Species Program established at UT Austin
7. Non-invasive first trimester blood test reliably detects Downs syndrome
8. Biomarker identification may lead to new noninvasive test for colorectal cancer detection
9. Researchers calculate the global highways of invasive marine species
10. New scientific studies reveal Midwestern frogs decline, mammal populations altered by invasive plant
11. Dirty dozen invasive species threaten UK
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Muscle-invasive and non-muscle invasive bladder cancers arise from different stem cells
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology: